Jagsonpal Pharmaceuticals Ltd — Quarterly Results & Earnings

₹184.03

+0.05%

Profit Growth YoY9.69%Latest quarter

Sales Growth YoY-0.29%Latest quarter

Sales CAGR 5Y11.13%5 year compound

Profit CAGR 5Y38.15%5 year compound

📋

Quarterly Performance

YoY Profit Growth+9.69%

📈 Moderate growth

YoY Sales Growth-0.29%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

13.66%

EPS Growth 5Y

37.78%

Interest Coverage

Higher = safer debt servicing

54.51

ROE

18.58%

ROCE

22.95%

💡

Growth Analysis

Jagsonpal Pharmaceuticals Ltd reported YoY profit growth of 9.69% and revenue growth of -0.29% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 11.13% and profits at 38.15% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Jagsonpal Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.